qPCRqPCR Services for Research, Drug Development & Clinical Validation
From custom assay development and optimization to fit-for-purpose validation and high-throughput sample analysis, SCD provides quantitative PCR services designed around your target, sample type, and study requirements. Our molecular biology specialists support exploratory research, preclinical development, and regulated bioanalysis through our laboratory in Gothenburg, Sweden.
GLP accredited by SWEDAC.
Trusted By
Quality assurance & compliance
We are accredited for Good Laboratory Practice (GLP) by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) for qPCR, dPCR, and molecular biology.
About qPCR
Quantitative PCR Services at SCD
Quantitative polymerase chain reaction (qPCR) enables sensitive measurement of specific DNA targets and, following reverse transcription, RNA targets. It supports applications ranging from gene expression and biomarker studies to vector biodistribution, shedding, and clinical sample analysis. At SCD, we develop, optimize, qualify, validate, and perform qPCR assays to meet each study's intended use. Our teams help select an appropriate analytical strategy, establish controls, evaluate performance, and translate measurements into interpretable results.
Our qPCR services are delivered through our Gothenburg laboratories, formerly known as TATAA Biocenter, now TATAA, an SCD company.
- Custom assay development: target-specific primer and probe design, feasibility assessment, and optimization.
- Research-to-regulated workflows: fit-for-purpose qualification and, where applicable, GLP/GCLP-aligned validation and sample analysis.
- Scalable analysis: singleplex or compatible multiplex assays using 96- and 384-well formats.
Specifications
qPCR Specifications & Technical Capabilities
An overview of our qPCR capabilities. Final assay configuration and regulatory scope are defined during project scoping.
| Specification | Details |
|---|---|
| Technology | Real-time quantitative PCR (qPCR); RT-qPCR for RNA targets |
| Target material | DNA; RNA following reverse transcription to cDNA |
| Sample inputs | Extracted nucleic acids from tissue, biofluids, and other qualified biological matrices |
| Quantification | Absolute quantification with calibrated standards; relative quantification with suitable reference genes and controls |
| Assay formats | Singleplex and multiplex, where compatible |
| Detection chemistry | Probe-based and dye-based approaches, including TaqMan and SYBR Green, subject to assay suitability |
| Throughput | 96- and 384-well formats |
| Instrumentation | QuantStudio™ 7 Pro Real-Time PCR System (Applied Biosystems™, Thermo Fisher Scientific) |
| Development | Primer/probe design, extraction and RT optimization, assay feasibility and performance evaluation |
| Validation characteristics | As relevant to intended use: specificity, sensitivity, accuracy, precision, linearity, range, and robustness |
| Quality framework | Research Use Only (RUO), qualified, or validated GLP/GCLP workflows as applicable to the specific study and laboratory scope |
| Deliverables | Quantitative results, QC summary, method details, and validation documentation as agreed |
Assay development
Custom qPCR Assay Development & Validation
A reliable qPCR assay begins with a method designed for its specific target, biological matrix, and intended use. Our scientists consider the full analytical workflow, from extraction and reverse transcription to amplification, data processing, and reporting, rather than treating PCR as an isolated step.
Every assay is evaluated experimentally. Extraction recovery, nucleic acid integrity, reverse transcription efficiency, amplification efficiency, matrix effects, and primer/probe specificity can all influence performance. For advanced therapy applications, factors such as free versus encapsidated AAV DNA, target length, nucleic acid modifications, and secondary structures may require additional assessment.
What our assay development service includes
- Study design and target selection: define analytes, specimen types, expected concentrations, and reporting requirements.
- Sample preparation: assess extraction recovery and, for RNA assays, reverse transcription performance.
- Primer and probe design: develop or evaluate target-specific assays and assess potential interference.
- Reaction optimization: evaluate chemistry, cycling conditions, amplification efficiency, specificity, and assay range.
- Qualification and validation: establish and test performance characteristics and acceptance criteria appropriate to the intended use.
Need a Custom-Developed or Validated Assay?
From assay design and optimization to method validation, our scientists develop fit-for-purpose molecular assays tailored to your research and regulatory requirements.
Quality control
Quality Control Throughout the qPCR Workflow
Reliable quantitative results depend on controls at every stage. We design QC strategies to detect contamination, monitor recovery and assay efficiency, and establish whether reported results meet predefined requirements.
- Extraction and RT controls: appropriate spike-in materials or external nucleic acid controls can help assess recovery and RT inhibition.
- No-RT controls: for RNA workflows, reactions without reverse transcriptase help identify genomic DNA interference.
- No-template controls (NTCs): included to monitor reagent and reaction contamination.
- Calibration standards and QC samples: known concentrations are used, where appropriate, to evaluate assay range, precision, accuracy, and standard curve performance.
- Run acceptance criteria: in validated assays, QC samples, calibration curves, negative controls, and sample replicates are assessed against predefined assay-specific criteria.
- Operational controls: reagent stability and storage conditions, instrument calibration, and documented procedures support consistent analysis.
The precise control panel and acceptance thresholds depend on the assay, matrix, intended use, and applicable quality framework. No universal CV%, RE%, R², or efficiency threshold should be implied across all qPCR methods.
qPCR workflow
From Study Design to Results
assay design
reporting
Step 1
Scientific consultation
We define your biological question, analyte, sample matrix, sample numbers, expected range, development stage, and required deliverables. We also identify any regulatory or documentation requirements.
Step 2
Feasibility and assay design
We review sample characteristics, extraction and RT requirements, assay chemistry, primer/probe strategy, and relevant controls. Feasibility work informs the proposed method and validation plan.
Step 3
Method execution and quality control
Our laboratory performs assay development, optimization, qualification or validation as agreed, followed by sample analysis. We monitor run performance against the appropriate predefined QC criteria.
Step 4
Data analysis and reporting
We review amplification data, calibration and normalization approaches, sample-level QC, and quantitative results. Your team receives agreed outputs and sufficient methodological context to interpret findings and plan next steps.
Applications
qPCR Applications in Drug Development
qPCR is used across discovery, translational research, and drug development wherever sensitive, target-specific nucleic acid measurement is required.
Gene Expression & Biomarker Analysis
Measure relative changes in gene expression, verify transcriptomic findings, and monitor selected biomarkers across treatment groups or time points.
AAV and Cell & Gene Therapy Studies
Support vector copy number, biodistribution, and shedding investigations through appropriately developed assays for relevant vector or transgene targets.
RNA Therapeutics & Molecular Targets
Quantify selected RNA-derived targets using RT-qPCR workflows designed around RNA integrity, extraction recovery, reverse transcription, and intended analytical use.
Clinical and Longitudinal Sample Analysis
Apply qualified or validated methods to selected biomarkers and nucleic acid targets in serial samples, where the assay and laboratory quality framework support the study requirements.
Our expertise
Decades of qPCR Expertise, Backed by International Standards
Formerly TATAA Biocenter
Our qPCR services are performed at SCD’s laboratories in Gothenburg, Sweden, at TATAA Biocenter, now TATAA, an SCD company. This team brings established expertise in molecular assay development, quality control, and regulated bioanalysis into SCD’s broader discovery-to-validation service portfolio.
TATAA contributed to the internationally recognized MIQE guidelines (Minimum Information for Publication of Quantitative Real-Time PCR Experiments), which promote transparent, reproducible qPCR study design, analysis, and reporting. These principles inform our approach to assay controls, performance evaluation, and documentation.
In 2024, TATAA also contributed to the publication “Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development,” developed with experts across the sector. The paper addresses practical considerations for assays supporting advanced therapy development.
Together with SCD’s single-cell, spatial, sequencing, and data science services in the Netherlands, our Gothenburg capabilities enable complementary discovery and targeted validation studies within one organization. We confirm the applicable GLP/GCLP scope and site-specific accreditation status for each project.
25+
Years of qPCR expertise
Building on TATAA's molecular biology experience since 2001
384
Well plate format
For high-throughput quantitative analysis
GLP
Accredited laboratory
SWEDAC-accredited qPCR capabilities in Gothenburg
How it works
Understanding qPCR: Technology & Quantification Methods
What is qPCR?
Quantitative PCR measures amplification of a selected nucleic acid target in real time using a fluorescent probe or dye. Fluorescence is recorded across PCR cycles, and the quantification cycle (Cq) indicates when the signal crosses a defined threshold. Under comparable assay conditions, a lower Cq generally corresponds to a greater starting amount of target nucleic acid.
For RNA targets, reverse transcription converts RNA to cDNA before amplification (RT-qPCR). Quantitative interpretation depends on the method, assay efficiency, calibration or normalization strategy, and appropriate quality controls.
Comparison
Absolute vs. Relative qPCR Quantification
| Absolute quantification | Relative quantification |
|---|---|
| Estimates target quantity using calibrated standards and a standard curve. | Compares normalized target abundance between samples or conditions. |
| Results may be reported in copies per reaction, copies/µL, or other defined units. | Results are typically expressed as fold changes or relative expression. |
| Common for vector DNA, viral targets, and copy-number measurements. | Common for gene expression and biomarker response studies. |
| Performance depends on standard quality and assay efficiency. | Performance depends on reference-gene stability, assay efficiency, and control selection. |
qPCR vs. dPCR: Which Method Fits Your Study?
qPCR is well suited to established, scalable target quantification and comparative expression studies. Digital PCR (dPCR) partitions reactions and can provide absolute target quantification without a conventional standard curve, making it useful for selected low-abundance or high-precision applications. The best choice depends on target concentration, required sensitivity and precision, sample matrix, throughput, and regulatory context.
Explore our Digital PCR (dPCR) services.
Wondering if this service can
help answer your biological question?
Request a quote today and find out how our expertise can support your research.
What our clients say
"The service of Single Cell Discoveries guarantees a smooth process between customer and company. In case of problems or questions, the scientists reacted competently and immediately, so that answers could be found quickly and flexibly."
"Fantastic job made by a really professional and friendly team. I strongly recommend Single Cell Discoveries for sequencing services."
Recent publications using qPCR
bioRxiv
A Double-Negative Prostate Cancer Subtype is Vulnerable to SWI/SNF-Targeting Degrader Molecules
bioRxiv
SP140 limits type I interferon-driven pathology, preserving T cell motility and promoting resistance in tuberculosis
Nature Communications
Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate commitment
npj Precision Oncology
A single-cell atlas reveals the tumorigenesis and microenvironment status of primary tracheobronchial tumors
Nature Cardiovascular Research
Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration
Research Square
GPR124/WNT signaling regulates hyaloid blood vessel regression and endothelial-mesenchymal transition
Case studies
Pioneering 10x Flex on OCT-Embedded Patient Brain Tissue
10x Genomics opened the gates for single-cell sequencing on non-fresh, non-thawed tissue with their Chromium Single Cell Gene Expression Flex (10x Flex) kit. Now, we have been successful in performing…
Immune Profiling of atherosclerosis reveals new therapeutic potential
A team of scientists uses 10x Genomics Single Cell Immune Profiling to characterize T cells in the atherosclerotic plaque. Their results redefine atherosclerosis as an autoimmune disease.
Mechanism of disease: a new hypothesis for atherosclerosis
To elucidate atherosclerosis’ mechanism of disease, Sheffield University researchers analyzed the transcriptomes of single endothelial cells.
Recent blogs related to qPCR
Linearity, Co-linearity, Robustness, Ruggedness and Stability in qPCR and dPCR Validation
Part 4 of the PCR Assay Validation Guide — The Final Chapter This post concludes SCD’s PCR Assay Validation Guide. In Part 1 we introduced the principles of assay development,…
Sensitivity and Specificity in Regulated Bioanalytical Assay Validation
Part 3 of the PCR Assay Validation Guide This post continues the PCR Assay Validation Guide. In Part 1 we introduced the principles of development, qualification and validation and the…
Precision and Accuracy in qPCR and dPCR Assay Validation
Part 2 of the PCR Assay Validation Guide In Part 1 of this guide, we discussed how assay validation begins with defining the context of use and understanding what decision…
Frequently Asked Questions
qPCR measures DNA targets during amplification. RT-qPCR includes a reverse-transcription step that converts RNA into cDNA before quantitative amplification, making it suitable for RNA expression and other RNA-target analyses.
Absolute qPCR estimates target quantity against known standards, while relative qPCR compares normalized target abundance between samples or conditions. The appropriate method depends on the biological question and desired reporting units.
Yes. Our scientists can assess target-specific assay design, sample preparation, primer/probe selection, amplification conditions, controls, and performance characteristics. Feasibility and validation scope are agreed during project planning.
SCD supports regulated qPCR workflows through its Gothenburg laboratory. Whether GLP, GCLP, or another framework applies depends on the intended use, study design, assay, and current site-specific quality scope; we confirm this before work begins.
qPCR can be performed on DNA or cDNA prepared from suitable biological matrices, including tissues and biofluids. Compatibility, extraction approach, input quality, and minimum material requirements are assessed for each project.
We use study-appropriate controls for extraction, reverse transcription, contamination, calibration, and run performance. Validated assays also apply predefined criteria for QC samples, calibration, and reportable sample measurements.
Yes. Target-specific qPCR assays may support AAV vector biodistribution, vector copy number, and shedding assessments. Assay design must account for the target and sample matrix, including potential differences between free and encapsidated vector DNA.
qPCR is often appropriate for routine high-throughput targeted quantification and relative expression analysis. dPCR can be advantageous for certain low-copy targets or applications requiring highly precise absolute quantification. Our scientists can help compare the methods for your intended use.
Share your target or analyte, sample matrix, estimated sample count, study stage, expected concentration range if known, required deliverables, timeline, and any quality or regulatory requirements.
Request a quote
Discuss Your qPCR Project With Our Scientists
Whether you need to develop a new assay, validate an existing method, or analyze samples at scale, our molecular biology specialists can help define a fit-for-purpose qPCR strategy. Tell us about your target, sample type, study stage, and reporting requirements, and we will discuss the most appropriate next steps.